24 December 2025 in Proceedings of the National Academy of Sciences
Neuromodulatory systems play an essential role in regulating brain states and functions. The canonical view is that the release of monoamines including norepinephrine (NE) and serotonin (5-HT) is high during wakefulness and attenuated during sleep, particularly during rapid eye movement (REM) sleep, whereas the cholinergic system is active during both wakefulness and REM sleep and quiescent during non–REM (NREM) sleep. Recent studies have revealed a slow and rhythmic release pattern of neuromodulators during NREM sleep that drives infraslow oscillation (ISO) (0.02 to 0.03 Hz) in the brain. A key question is whether/how the release of different neuromodulators during sleep is coordinated. In this study, we combined 2-site fiber photometry with electroencephalogram/electromyography recording to monitor the release of NE, 5-HT, and acetylcholine in the cortex and hippocampus during sleep and wake cycles. We found that the ISO of these neuromodulators is synchronized during NREM sleep. The synchrony between neuromodulatory systems increases in the oscillatory cycles leading to arousal. Furthermore, pharmacological inhibition of either the 5-HT or NE system eliminates the oscillation of other neuromodulators during NREM sleep. Optogenetic activation of 5-HT or NE neurons during NREM sleep induces the release of other neuromodulators in the absence of sleep-to-wake transitions. These results suggest that the rhythmic neuromodulator releases are highly coordinated in the brain. The synchrony among multiple neuromodulatory systems across brain regions provides a powerful neural mechanism to orchestrate sleep architecture and sleep-related neural processes.
13 February 2026 in Nature Communications
Recent studies have revealed many alternative exons differentially spliced across diverse neuron types in the mammalian brain, but their links to neuronal physiology remain unclear. Here we characterize a deeply conserved microexon E35a in Ank3 encoding ankyrin-G (AnkG), a multifaceted adaptor protein best known as a master organizer of the axon initial segment (AIS) and as a leading genetic risk factor for bipolar disorder. E35a is predominantly skipped in cortical glutamatergic neurons but included in cortical GABAergic neurons and cerebellar neurons, which is dictated by multiple neuronal splicing factors. In E35a-deletion mice we generated, interneurons show increased excitability and somatic Ca2+ activity, without disruption in AIS. Biochemical analyses suggest that E35a inclusion facilitates AnkG interaction with a protein complex involving inositol trisphosphate receptors (InsP3Rs) important for intracellular Ca2+ signaling. Alternative splicing therefore allows AnkG to modulate neuron type-specific excitability in addition to its ubiquitous pan-neuronal role in organizing the AIS.
28 October 2026 in Cell Reports
ARAngie Maldonado Rodriguez
Angie Maldonado Rodriguez
+6
14 November 2026 in SLEEP
ARAngie N Maldonado Rodriguez
Angie N Maldonado Rodriguez
+2
Although disruption of sleep behavior is prevalent across different neurodegenerative diseases, there is little understood about the molecular mechanisms that tie them together. To explore this relationship, we turned to the autosomal dominant disorder Huntington’s disease (HD), which shares many features common to more prevalent sporadic diseases, such as abnormal protein accumulation, early cognitive changes, and cell type specific degeneration. Moreover, HD patients suffer from sleep disruption, which precedes the appearance of core clinical features of the disease. We have previously found that upregulation of selective autophagy can prevent the aberrant protein accumulation that is typical of HD and other disorders. Thus, given the robust modeling of HD, we performed sleep analysis in the presence or absence of the upregulation of selective autophagy, to test the hypothesis that the proteinopathy significantly contributes to sleep dysfunction. We found that HD mice display rapid eye movement (REM) sleep impairments and protein aggregation in sleep-related regions including the nucleus accumbens and amygdala. Augmenting selective autophagy in the brain slowed aberrant protein accumulation and ameliorated REM sleep deficits in HD mice. Taken together, these data suggest that the disruption of protein homeostasis may play a key role in sleep dysfunction and disease.